- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04881422
Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project
Sport, Rehabilitation and Nutrition in Multiple Sclerosis: An Innovative Multidisciplinary High Impact Intervention for the Lifestyle Change
Only a limited percentage of persons with MS (pwMS) participate to multidisciplinary rehabilitation because of poor support, knowledge and motivation. The investigators reasoned that pwMS should be more effectively prepared to increase their adherence. This study propose the implementation of an innovative collaborative approach, called "brief high-impact preparatory experience" (b-HIPE), inspired by an overarching model based on the interplay between competence, motivation and opportunity to increase in a short time awareness and motivation of pwMS.
The aim of the study is the evaluation of its feasibility. For this pilot study the investigator chose a single-group design with repeated measurements at baseline and post intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laura LM Mendozzi, MD
- Phone Number: +39 02 40308571
- Email: lmendozzi@dongnocchi.it
Study Locations
-
-
-
Milan, Italy
- Recruiting
- IRCCS Fondazione Don Carlo Gnocchi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 18 to 70 years
- EDSS ranging from 1 to 7.5.
- pwMS with who are on a western diet
- stabilized medical therapy and clinical conditions
- pwMS with a motor control of upper limbs sufficient to maneuver a tiller
Exclusion Criteria:
- Heavy smoking, alcohol and drugs abuse
- severe cognitive impairment
- dysphagia and/or comorbidities requiring protected environments and specific medical assistance
- blindness and severe visual disturbances (included severe nystagmus)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
A group of pwMS participate in a multidimensional integrate high-motivating rehabilitation program for the change of lifestyle and bad habits.
|
The intervention consists in a one-week intensive rehabilitation in which participants underwent to a multidimensional rehabilitation composed by physical rehabilitation, mental wellbeing, a proper diet and engaging physical activity (a sail course).
Digital motivating reinforcements are proposed to the participants with the aim to maintain the correct lifestyle learned in the B-HIPE program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FS-36 Health Related Quality of Life (HRQoL)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
Questionnaire to Measure Health-Related Quality of Life
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
The Fatigue Severity Scale (FSS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
Questionnaire to Measure the fatigue
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
Food frequency questionnaire (FFQ)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
Questionnaire to evaluate usual frequency of foods and beverages
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MSIS29- Multiple Sclerosis Impact Scale
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
A scale for the evaluation of the impact of MS on day-to-day life
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
MOS Sleep Scale (MOSS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
A scale for the evaluation of the quality and the quantity of sleep
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
Restless Legs Scale (RLS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
A scale for the evaluation of the restless legs syndrome
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
Six minute walking test (6MWT)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
An exercise test used to assess aerobic capacity and endurance
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
A self-assessment scale for detecting states of depression and anxiety
|
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07_23/05/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States